Search research articles
Contact Us
Filters
Showing results (911-920 of 1,042) with videos related to
Page
of 105
Sort By:
American Journal of Human Genetics
|
December 1, 2014
A rare functional noncoding variant at the GWAS-implicated MIR137/MIR2682 locus might confer risk to schizophrenia and bipolar disorder
Jubao Duan, Jianxin Shi, Alessia Fiorentino, et al.
The New England Journal of Medicine
|
December 4, 2018
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Stephen J Schuster, Michael R Bishop, Constantine S Tam, et al.
The International Journal of Neuropsychopharmacology
|
January 10, 2016
Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis
Eric Huang, Clement C Zai, Amanda Lisoway, et al.
Journal for Immunotherapy of Cancer
|
September 29, 2022
Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)
Michael B Atkins, Hamzah Abu-Sbeih, Paolo A Ascierto, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 19, 2023
Epigenetic Control of Translation Checkpoint and Tumor Progression via RUVBL1-EEF1A1 Axis
Mingli Li, Lu Yang, Anthony K N Chan, et al.
Nature
|
July 17, 2020
Nucleolar RNA polymerase II drives ribosome biogenesis
Karan J Abraham, Negin Khosraviani, Janet N Y Chan, et al.
Journal of Medicinal Chemistry
|
July 20, 1999
Identification of pharmacokinetically stable 3, 10-dibromo-8-chlorobenzocycloheptapyridine farnesyl protein transferase inhibitors with potent enzyme and cellular activities
A G Taveras, J Deskus, J Chao, et al.
Cancer Research
|
November 11, 1998
Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice
M Liu, M S Bryant, J Chen, et al.
Nature Communications
|
June 2, 2025
Loss of CD98HC phosphorylation by ATM impairs antiporter trafficking and drives glutamate toxicity in Ataxia telangiectasia
July Carolina Romero, Sonal S Tonapi, Manish Parihar, et al.
Blood
|
April 2, 2011
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States
Jeffrey I Cohen, Elaine S Jaffe, Janet K Dale, et al.
Page
of 105
Search research articles
Search
Showing results (911-920 of 1,042) with videos related to
Sort By:
Page
of 105
American Journal of Human Genetics
|
December 1, 2014
A rare functional noncoding variant at the GWAS-implicated MIR137/MIR2682 locus might confer risk to schizophrenia and bipolar disorder
Jubao Duan, Jianxin Shi, Alessia Fiorentino, et al.
The New England Journal of Medicine
|
December 4, 2018
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Stephen J Schuster, Michael R Bishop, Constantine S Tam, et al.
The International Journal of Neuropsychopharmacology
|
January 10, 2016
Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis
Eric Huang, Clement C Zai, Amanda Lisoway, et al.
Journal for Immunotherapy of Cancer
|
September 29, 2022
Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC)
Michael B Atkins, Hamzah Abu-Sbeih, Paolo A Ascierto, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 19, 2023
Epigenetic Control of Translation Checkpoint and Tumor Progression via RUVBL1-EEF1A1 Axis
Mingli Li, Lu Yang, Anthony K N Chan, et al.
Nature
|
July 17, 2020
Nucleolar RNA polymerase II drives ribosome biogenesis
Karan J Abraham, Negin Khosraviani, Janet N Y Chan, et al.
Journal of Medicinal Chemistry
|
July 20, 1999
Identification of pharmacokinetically stable 3, 10-dibromo-8-chlorobenzocycloheptapyridine farnesyl protein transferase inhibitors with potent enzyme and cellular activities
A G Taveras, J Deskus, J Chao, et al.
Cancer Research
|
November 11, 1998
Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice
M Liu, M S Bryant, J Chen, et al.
Nature Communications
|
June 2, 2025
Loss of CD98HC phosphorylation by ATM impairs antiporter trafficking and drives glutamate toxicity in Ataxia telangiectasia
July Carolina Romero, Sonal S Tonapi, Manish Parihar, et al.
Blood
|
April 2, 2011
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States
Jeffrey I Cohen, Elaine S Jaffe, Janet K Dale, et al.
Page
of 105